NEW YORK (TheStreet) -- RATINGS CHANGES AbbVie was upgraded at BMO Capital to outperform from market perform. Valuation call, based on a 12-month price target of $68, BMO Capital said. Carpenter was downgraded at Sterne Agee to neutral from buy. Twelve-month price target is $42. Estimates were also cut, given lower expected utilization, Sterne Agee said. Must Read: 11 Safe High-Yield Dividend Stocks for Times of Volatility and Uncertainty Coach was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: COH Ratings Report. Freeport-McMoRan was upgraded at Citigroup to buy. Twelve-month price target is $23. Copper market should improve by 2016, Citigroup said. Louisiana-Pacific was upgraded at RBC Capital to sector perform from underperform. Twelve-month price target is $15. Prices appear to have bottomed and can improve, along with season demand, RBC Capital said. Nielsen was downgraded at Pivotal Research to hold from buy. Valuation call, based on a 12-month price target of $49, Pivotal Research said. OneBeacon Insurance was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: OB Ratings Report. Sempra Energy was upgraded at Goldman Sachs to buy. Twelve-month price target is $130. Company has a robust growth outlook, Goldman Sachs said. UnitedHealth was upgraded at Jefferies to buy from hold. Company gain can market share in fast growing areas, Jefferies said. Twelve-month price target is $141. Must Read: Warren Buffett's Top 10 Dividend Stocks Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes," which is available only to Real Money subscribers. To find out how to become a subscriber, please click here. Follow TheStreet on Twitter and become a fan on Facebook.
Click to view a price quote on ABBV. Click to research the Drugs industry.
from Latest TSC Headlines http://feeds.thestreet.com/~r/tsc/feeds/rss/latest-stories/~3/ey_BQ6u1Pxk/analysts-actions--abbvie-freeport-mcmoran-nielsen-and-more.html
No comments:
Post a Comment